Effect of microRNA‐34a in cell cycle, differentiation, and apoptosis: A review

The tumor suppressor gene p53 was shown to directly regulate the expression of microRNA‐34a (miR‐34a). miR‐34a regulates a plethora of target proteins, which are involved in cell cycle, apoptosis, differentiation, and cellular development.miR‐34a resides in the region of chromosome 1p36.23, which is commonly deleted in many tumor types, while it results in the loss expression of miR‐34a. The promoters of the miR‐34a gene subject to inactivation by CpG methylation also induce the loss expression of miR‐34a. Ectopic miR‐34a expression induces apoptosis, cell cycle arrest, and differentiation or reduces migration. This review summarizes the progress regarding the role of miR‐34a in cell cycle, differentiation, and apoptosis. © 2011 Wiley Periodicals, Inc. J Biochem Mol Toxicol 26:79–86 2012; View this article online at wileyonlinelibrary.com. DOI 10.1002/jbt.20412

[1]  Sharon J. Diskin,et al.  A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene , 2008, Molecular Cancer Research.

[2]  Supratim Choudhuri,et al.  Small noncoding RNAs: Biogenesis, function, and emerging significance in toxicology , 2010, Journal of biochemical and molecular toxicology.

[3]  Jian Li,et al.  MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. , 2010, American journal of physiology. Endocrinology and metabolism.

[4]  R. Stallings,et al.  MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells , 2007, Oncogene.

[5]  S. Elmore.  Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[6]  J. Ericsson,et al.  YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  N. Jones,et al.  Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53 , 2005, The Journal of cell biology.

[8]  M. Yamakuchi,et al.  miR-34a repression of SIRT1 regulates apoptosis , 2008, Proceedings of the National Academy of Sciences.

[9]  D. Hu,et al.  MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. , 2009, Investigative ophthalmology & visual science.

[10]  Jennifer A Fulcher,et al.  Phagocytes, Granulocytes, and Myelopoiesis , 2022 .

[11]  N. Shomron,et al.  Teratogen-induced alterations in microRNA-34, microRNA-125b and microRNA-155 expression: correlation with embryonic p53 genotype and limb phenotype , 2010, BMC Developmental Biology.

[12]  G. Brodeur.  Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.

[13]  Wei Wang,et al.  MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. , 2007, Cancer research.

[14]  M. Katoh,et al.  Integrative genomic analyses on GLI2: mechanism of Hedgehog priming through basal GLI2 expression, and interaction map of stem cell signaling network with P53. , 2008, International journal of oncology.

[15]  M. Toyota,et al.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. , 2008, Cancer research.

[16]  Ying Feng,et al.  Supplemental Data P53-mediated Activation of Mirna34 Candidate Tumor-suppressor Genes , 2022 .

[17]  Naoto Tsuchiya,et al.  Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells , 2007, Proceedings of the National Academy of Sciences.

[18]  J. Schelter,et al.  Myc overexpression brings out unexpected antiapoptotic effects of miR-34a , 2011, Oncogene.

[19]  Y. Pilpel,et al.  p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC , 2010, Cell Death and Differentiation.

[20]  T. Giordano,et al.  C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells , 2008, Oncogene.

[21]  A. Mills,et al.  The quest for the 1p36 tumor suppressor. , 2008, Cancer research.

[22]  Qing-Rong Chen,et al.  Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. , 2011, Journal of proteome research.

[23]  Michael A. Beer,et al.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.

[24]  Gozoh Tsujimoto,et al.  MicroRNA-34a Inhibits Cell Proliferation by Repressing Mitogen-Activated Protein Kinase Kinase 1 during Megakaryocytic Differentiation of K562 Cells , 2010, Molecular Pharmacology.

[25]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[26]  Yunqing Li,et al.  MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. , 2009, Cancer research.

[27]  Giuseppe Basso,et al.  miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. , 2009, Cancer research.

[28]  L. Lim,et al.  A microRNA component of the p53 tumour suppressor network , 2007, Nature.

[29]  R. Stallings,et al.  MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma , 2011, BMC Cancer.

[30]  Moshe Oren,et al.  Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. , 2007, Molecular cell.

[31]  Y. Mo,et al.  A Pathway Involving Farnesoid X Receptor and Small Heterodimer Partner Positively Regulates Hepatic Sirtuin 1 Levels via MicroRNA-34a Inhibition* , 2010, The Journal of Biological Chemistry.

[32]  Yasunori Fujita,et al.  Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. , 2008, Biochemical and biophysical research communications.

[33]  Min Zhang,et al.  Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres , 2008, BMC Cancer.

[34]  M. Yamakuchi,et al.  MicroRNA-34a regulation of endothelial senescence. , 2010, Biochemical and biophysical research communications.

[35]  M. Busslinger.  Transcriptional control of early B cell development. , 2004, Annual review of immunology.

[36]  Yi Tie,et al.  miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. , 2009, Cancer letters.

[37]  Ryan M. O’Connell,et al.  MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. , 2010, Immunity.

[38]  G. Hannon,et al.  Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.

[39]  J. Nardone,et al.  Foxp1 is an essential transcriptional regulator of B cell development , 2006, Nature Immunology.

[40]  M. A. Valencia Sanchez.  Control of translation and mRNA degradation by miRNAs and siRNAs , 2006 .

[41]  H. Hermeking.  The miR-34 family in cancer and apoptosis , 2010, Cell Death and Differentiation.

[42]  T. Russo,et al.  miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  V. Tarasov,et al.  Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest , 2007, Cell cycle.

[44]  S. Grossman,et al.  Yin Yang 1 Is a Negative Regulator of p53 , 2004, Cell.